14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Hold
Today ADMS ranks #5575 as hold candidate. Get a Free Stock at Robinhood
Stronger Stock

$8.01 (0.12%)

Volume: 1M

Closed: Oct 22, 2021

Hollow Logo Score: 0.158

Adamas Pharmaceuticals Stock Forecast

$8.01 (0.12%)

Volume: 1M

Closed: Oct 22, 2021

Score Hollow Logo 0.158

Adamas Pharmaceuticals Stock Price (Quote) NASDAQ:ADMS

$8.01 ( 0.12% ) Friday, 22nd Oct 2021

Range Low Price High Price Comment
30 days $4.48 $8.10 Friday, 22nd Oct 2021 ADMS stock ended at $8.01. This is 0.12% more than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 0.69% from a day low at $7.99 to a day high of $8.05.
90 days $4.02 $8.10
52 weeks $2.96 $9.15

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
2021-10-22 $8.00 $8.05 $7.99 $8.01 1 297 558
2021-10-21 $8.00 $8.00 $7.97 $8.00 1 046 820
2021-10-20 $8.00 $8.03 $7.95 $7.97 1 718 303
2021-10-19 $8.03 $8.05 $7.82 $8.00 2 773 949
2021-10-18 $8.07 $8.08 $8.00 $8.03 3 775 433
2021-10-15 $8.07 $8.08 $8.06 $8.07 953 529
2021-10-14 $8.07 $8.08 $8.06 $8.07 1 899 105
2021-10-13 $8.06 $8.07 $8.05 $8.07 2 811 441
2021-10-12 $8.05 $8.09 $8.04 $8.08 4 504 484
2021-10-11 $7.93 $8.10 $7.90 $8.07 32 230 354
2021-10-08 $4.51 $4.73 $4.49 $4.61 63 175
2021-10-07 $4.67 $4.71 $4.49 $4.51 82 253
2021-10-06 $4.54 $4.70 $4.48 $4.67 100 169
2021-10-05 $4.66 $4.93 $4.51 $4.55 109 432
2021-10-04 $4.72 $4.77 $4.60 $4.64 87 522
2021-10-01 $4.89 $4.89 $4.68 $4.76 62 638
2021-09-30 $4.90 $4.91 $4.77 $4.91 45 872
2021-09-29 $5.15 $5.16 $4.86 $4.87 111 541
2021-09-28 $5.14 $5.20 $5.01 $5.16 193 789
2021-09-27 $4.84 $5.24 $4.72 $5.18 387 359
2021-09-24 $4.81 $4.96 $4.77 $4.88 72 706
2021-09-23 $4.83 $4.89 $4.74 $4.86 71 301
2021-09-22 $4.90 $4.90 $4.76 $4.78 106 681
2021-09-21 $4.87 $4.97 $4.75 $4.88 165 576
2021-09-20 $4.92 $4.94 $4.67 $4.80 164 449
2021-09-17 $4.71 $5.05 $4.52 $5.05 414 634
2021-09-16 $4.62 $4.75 $4.50 $4.75 156 202
2021-09-15 $4.53 $4.78 $4.51 $4.65 316 108
2021-09-14 $4.55 $4.60 $4.49 $4.55 202 100
2021-09-13 $4.61 $4.67 $4.49 $4.56 140 533
2021-09-10 $4.56 $4.67 $4.46 $4.55 135 374
2021-09-09 $4.57 $4.65 $4.51 $4.56 85 618
2021-09-08 $4.60 $4.61 $4.49 $4.56 82 494
2021-09-07 $4.76 $4.82 $4.57 $4.59 156 911
2021-09-03 $4.73 $4.83 $4.66 $4.75 93 432
2021-09-02 $4.64 $4.74 $4.63 $4.73 77 441
2021-09-01 $4.72 $4.78 $4.58 $4.65 46 769
2021-08-31 $4.57 $4.78 $4.56 $4.71 159 994
2021-08-30 $4.50 $4.69 $4.47 $4.53 100 035
2021-08-27 $4.67 $4.73 $4.41 $4.48 357 707
2021-08-26 $4.72 $4.82 $4.67 $4.70 73 004
2021-08-25 $4.45 $4.83 $4.45 $4.67 138 958
2021-08-24 $4.63 $4.63 $4.42 $4.48 212 376
2021-08-23 $4.46 $4.69 $4.31 $4.63 226 200
2021-08-20 $4.25 $4.43 $4.17 $4.34 131 803
2021-08-19 $4.14 $4.32 $4.09 $4.26 327 580
2021-08-18 $4.32 $4.37 $4.13 $4.20 302 817
2021-08-17 $4.11 $4.39 $4.11 $4.32 216 090
2021-08-16 $4.50 $4.51 $4.02 $4.16 564 805
2021-08-13 $4.55 $4.59 $4.46 $4.50 1 122 693

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT